Positive KarXT Blood Pressure Data; ADHD Manufacturing Cover-Up? 'Profound Autism'

(MedPage Today) -- Karuna Therapeutics released reassuring phase Ib data mitigating blood pressure concerns with its investigational psychiatric drug KarXT; the novel agent is under review with the FDA for an indication in schizophrenia. A Massachusetts...
Source: MedPage Today Psychiatry - Category: Psychiatry Source Type: news